NEWS
06
Apr
2017
Prof. Michelle Khine named Fellow of the National Academy of Inventors

Novoheart scientific co-founder and Scientific Advisory Board member Prof. Michelle Khine has recently been named a fellow of the National Academy of Inventors (NAI), the highest professional distinction accorded solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.

12
Mar
2017
Novoheart signs exclusive licensing agreement with the Regents of the University of California for heart cell alignment technologies

Novoheart enters into an exclusive licensing agreement with the Regents of the University of California for technologies developed by Professor Michelle Khine and Professor Ronald Li, scientific co-founders of Novoheart. These inventions allow Novoheart to utilize human pluripotent stem cell-derived heart muscle cells (cardiomyocytes) to produce engineered and aligned cellular platforms, which provide optimal use as drug screening and disease modelling tools.

11
Jan
2017
R&D Project funded by Innovation and Technology Fund (ITF) of the Hong Kong government is completed

The 2-year R&D Project funded by the Innovation and Technology Fund (ITF) grant, administered by the Innovation and Technology Commission (ITC) of the Hong Kong Special Administrative Region (HKSAR) government, has been successfully completed. The project culminates in the establishment of drug screening platforms using an array of new-generation human heart tissue prototypes, and multiple patent applications for technologies developed within the project.

27
Sep
2016
Patent on "Multi-scale Wrinkles for Functional Alignment of Stem Cells and Cardiac Derivatives" issued in the U.S.

Novoheart co-founders Professors Michelle Khine and Ronald Li’s invention, titled "Multi-scale Wrinkles for Functional Alignment of Stem Cells and Cardiac Derivatives", is issued in the U.S. as a patent (Patent No. US9,452,564 B2), by the U.S. Trademark & Patent Office (USPTO).